Citigroup Lowers Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $42.00
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its price target reduced by Citigroup from $45.00 to $42.00 in a research report sent to investors on Tuesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. Other research analysts also recently issued reports about the company. The Goldman Sachs Group lifted their target price […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its price target reduced by Citigroup from $45.00 to $42.00 in a research report sent to investors on Tuesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. Other research analysts also recently issued reports about the company. The Goldman Sachs Group lifted their target price […]
